The effect of different species aminopeptidase N structure on the activity screening of aminopeptidase N inhibitor

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 10, 2010, Pages 1658-1665

  Wang, Xuejian ^a   Zhang, Lei ^a   Yang, Kanghui ^a   Zhang, Cai ^a   Zhang, Jian ^a   Fang, Hao ^a   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Aminopeptidase N inhibitor; Crystal structure; Invasion; Migration

Indexed keywords

16L; BESTATIN; ENZYME INHIBITOR; LEUCINE; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DOSE RESPONSE; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR DOCKING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CLEAVAGE; SEQUENCE ALIGNMENT; SWINE; TUMOR CELL;

EID: 77958008548     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1658     Document Type: Article

References (27)

1. Look A. T., Ashmun R. A., Shapiro L. H., Peiper S. C., J. Clin. Invest., 83, 1299-1307 (1989).
2. Hooper N. M., FEBS Lett., 354, 1-6 (1994).
3. Shipp M. A., Look A. T., Blood, 82, 1052-1070 (1993).
4. Lendeckel U., Kahne T., Riemann D., Neubert K., Arndt M., Reinhold D., Adv. Exp. Med. Biol., 477, 1-24 (2000).
5. Terauchi M., Kajiyama H., Shibata K., Ino K., Nawa A., Mizutani S., Kikkawa F., BMC Cancer, 7, 140 (2007).
6. Bhagwat S. V., Lahdenranta J., Giordano R., Arap W., Pasqualini R., Shapiro L. H., Blood, 97, 652-659 (2001).
7. Wulfaenger J., Niedling S., Riemann D., Seliger B., Mol. Membr. Biol., 25, 72-82 (2008).
8. Umezawa H., Aoyagi T., Suda H., Hamada M., Takeuchi T., J. Antibiot., 29, 97-99 (1976).
9. Xu Y., Lai L. T., Gabrilove J. L., Scheinberg D. A., Clin. Cancer Res., 4, 171-176 (1998).
10. Urabe A., Mutoh Y., Mizoguchi H., Takaku F., Ogawa N., Ann. Hematol., 67, 63-66 (1993).
11. Li Q., Fang H., Wang X., Hu L., Xu W., Eur. J. Med. Chem., 44, 4819-4825 (2009).
12. Shang L., Fang H., Zhu H., Wang X., Wang Q., Mu J., Wang B., Kishioka S., Xu W., Bioorg. Med. Chem., 17, 2775-2784 (2009).
13. Mou J., Fang H., Jing F., Wang Q., Liu Y., Zhu H., Shang L., Wang X., Xu W., Bioorg. Med. Chem., 17, 4666-4673 (2009).
14. Long Q., Huang L., Li Z., Ye Q., Process. Biochem., 43, 438-444 (2008).
15. Raccor B. S., Vogt A., Sikorski R. P., Madiraju C., Balachandran R., Montgomery K., Shin Y., Fukui Y., Jung W. H., Curran D. P., Day B. W., Mol. Pharmacol., 73, 718-726 (2008).
16. Tian M., Huitema E., Da C. L., Torto-Alalibo T., Kamoun S., J. Biol. Chem., 279, 26370-26377 (2004).
17. Venalainen J. I., Garcia-Horsman J. A., Forsberg M. M., Jalkanen A., Wallen E. A., Jarho E. M., Christiaans J. A., Gynther J., Mannisto P. T., Biochem. Pharmacol., 71, 683-692 (2006).
18. Petrovic N., Schacke W., Gahagan J. R., O'Conor C. A., Winnicka B., Conway R. E., Mina-Osorio P., Shapiro L. H., Blood, 110, 142-150 (2007).
19. Girard E., Stelter M., Vicat J., Kahn R., Acta Crystallogr. D Biol. Crystallogr., 59, 1914-1922 (2003).
20. Wallace A. C., Laskowski R. A., Thornton J. M., Protein Eng., 8, 127-134 (1995).
21. Kido A., Krueger S., Haeckel C., Roessner A., Clin. Exp. Metastasis, 20, 585-592 (2003).
22. Kido A., Krueger S., Haeckel C., Roessner A., Clin. Exp. Metastasis, 17, 857-863 (1999).
23. John A., Tuszynski G., Pathol. Oncol. Res., 7, 14-23 (2001).
24. Tokuhara T., Hattori N., Ishida H., Hirai T., Higashiyama M., Kodama K., Miyake M., Clin. Cancer Res., 12, 3971-3978 (2006).
25. Ishii K., Usui S., Sugimura Y., Yamamoto H., Yoshikawa K., Hirano K., Biol. Pharm. Bull., 24, 226-230 (2001).
26. Ishii K., Usui S., Sugimura Y., Yoshida S., Hioki T., Tatematsu M., Yamamoto H., Hirano K., Int. J. Cancer, 92, 49-54 (2001).
27. Ikeda N., Nakajima Y., Tokuhara T., Hattori N., Sho M., Kanehiro H., Miyake M., Clin. Cancer Res., 9, 1503-1508 (2003).